Citius Oncology gets Nasdaq extension to April 19, 2027, to meet minimum bid price rule
CTOR•Citius Oncology received an extension until April 19, 2027, to meet Nasdaq’s $1 minimum bid-price requirement, which requires a closing bid of at least $1 for 10 consecutive business days.
1. Compliance deadline extended
Nasdaq gave Citius Oncology until April 19, 2027, to meet the $1 minimum bid-price requirement. The stock must close at a bid price of at least $1 for 10 consecutive business days. If it does not regain compliance by the deadline, Nasdaq would issue a delisting notice, which the company may appeal to a hearings panel. The common stock remains listed on the Nasdaq Capital Market under CTOR while the company evaluates compliance options.
